<p>隨着全球市場對近期經濟變化的反應，包括美聯儲的降息和美國與中國之間持續的貿易討論，小型股對這些變化表現出顯著的敏感性，像羅素 2000 指數經歷了顯著的漲幅。在這個動態環境中，識別亞洲有前景的小型股可以為尋求增長潛力的投資者提供獨特的機會，尤其是在不斷變化的市場條件下。</p>
<h3>亞洲十大未被發現的基本面強勁的寶藏股</h3>
<table>
<thead>
<tr>
<th>名稱</th>
<th>負債權益比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>瑞豐室內設計</td>
<td>NA</td>
<td>32.58%</td>
<td>38.70%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>杭州富通氣體低温集團</td>
<td>NA</td>
<td>15.44%</td>
<td>21.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>江陰海達橡塑</td>
<td>13.80%</td>
<td>8.51%</td>
<td>-6.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集團</td>
<td>2.04%</td>
<td>-5.07%</td>
<td>5.13%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>宜賓市商業銀行</td>
<td>82.57%</td>
<td>-1.19%</td>
<td>15.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>幸運水泥</td>
<td>47.61%</td>
<td>4.43%</td>
<td>16.92%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>廣東創科醫療電子</td>
<td>14.33%</td>
<td>-9.94%</td>
<td>1.91%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>納城物業服務集團有限公司</td>
<td>6.90%</td>
<td>6.11%</td>
<td>-8.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>中國醫院集團</td>
<td>137.48%</td>
<td>28.23%</td>
<td>50.23%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>SBS 菲律賓</td>
<td>29.71%</td>
<td>3.10%</td>
<td>-49.78%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲未被發現的基本面強勁的寶藏股篩選器中的 2395 只股票的完整列表。</p>
<p>以下是篩選器中一些選擇的預覽。</p>
<h2>廣東富信科技 (SHSE:688662)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 廣東富信科技有限公司從事半導體熱電材料的研究、開發、生產和銷售，市值約為 51 億元人民幣。</p>
<p><strong>運營：</strong> 該公司專注於半導體熱電材料，市值約為 51 億元人民幣。其收入主要通過銷售這些材料獲得，同時管理與研發和生產相關的成本。財務表現受到其毛利率趨勢的影響。</p>
<p>富信科技作為半導體領域的較小參與者，過去一年表現出 68.6% 的盈利增長，超過行業的 10.4%。儘管表現強勁，但其盈利在過去五年中年均下降 32.2%。最近的財務數據顯示，2025 年上半年銷售額為 2.5921 億元人民幣，而去年為 2.5106 億元人民幣，淨收入略降至 2035 萬元人民幣，之前為 2226 萬元人民幣。該公司現金多於債務，並保持正的自由現金流，儘管其股價最近波動較大。</p>
<ul>
<li>在這裏深入瞭解廣東富信科技的具體情況，查看我們的詳細健康報告。</li>
<li>查看我們的歷史表現報告，以獲取廣東富信科技過去表現的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c000b4fb-abb7-48d0-a59e-8933a5bb9153/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c000b4fb-abb7-48d0-a59e-8933a5bb9153/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月，SHSE:688662 負債權益比</p>
<h2>MYS 集團 (SZSE:002303)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> MYS 集團有限公司在中國及國際上開發、生產和銷售包裝產品，市值為 72 億元人民幣。</p>
<p><strong>運營：</strong> MYS 集團通過開發、生產和銷售包裝產品在中國及國際上獲得收入。公司的市值約為 72 億元人民幣。</p>
<p>MYS 集團憑藉其強勁的財務表現引起關注，2025 年上半年淨收入為 1.761 億元人民幣，較去年 1501.5 萬元人民幣有所增長。公司的盈利增長為 25.8%，顯著超過包裝行業的-3.1%，突顯其強大的市場地位和運營效率。儘管負債權益比在五年內從 17.6% 上升至 30.8%，MYS 仍保持現金多於總債務，表明其財務健康和穩定，能夠輕鬆覆蓋利息支付。此外，交易價格略低於公允價值，表明對於尋求增長機會的投資者在亞洲動態市場中的潛在吸引力。</p>
<ul>
<li>在這裏通過我們的綜合健康報告深入瞭解 MYS 集團的複雜情況。</li>
<li>通過訪問我們的歷史表現報告評估 MYS 集團的歷史表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/156d5255-b010-4783-bcd2-6ceef5f53187/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/156d5255-b010-4783-bcd2-6ceef5f53187/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 9 月，SZSE:002303 盈利和收入增長</p>
<h2>廈門唯科模具與塑料工程 (SZSE:301196)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 廈門唯科模具與塑料工程有限公司專注於高精度模具、注塑產品和健康產品的生產與銷售，市值約為 132.9 億元人民幣。</p>
<p><strong>運營：</strong> 唯科模具的收入主要來自高精度模具、注塑產品和健康產品的生產與銷售，總計為 20.9 億元人民幣。該公司的市值約為 132.9 億元人民幣。</p>
<p>廈門唯科模具與塑料工程作為行業中的較小參與者，最近其盈利增長 14.4%，超過了更廣泛的機械行業 4% 的增長。儘管最近幾個月股價波動較大，但該公司展現出強勁的財務健康，現金多於總債務，並保持正的自由現金流。其負債權益比在五年內從 0.7 上升至 1.3，但利潤仍能很好地覆蓋利息支付。最近的交易包括一項價值 2.8 億元人民幣的 2.9% 股份的顯著收購，反映出投資者的信心和在這一細分市場未來增長的潛力。</p>
<ul>
<li>在我們的健康報告中更深入地瞭解廈門唯科模具與塑料工程的潛力。</li>
<li>探索歷史數據，以追蹤廈門唯科模具與塑料工程在我們過去部分的表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eac44be0-d376-4d04-a061-9284cfecf929/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eac44be0-d376-4d04-a061-9284cfecf929/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:301196 截至 2025 年 9 月的收益和收入增長</p>
<h2>關鍵要點</h2>
<ul>
<li>使用我們的篩選器在這裏深入瞭解 2395 個具有強大基本面的亞洲未被發現的寶石。</li>
<li>是這些公司的股東之一嗎？通過在 Simply Wall St 中添加您的投資組合，確保您不會被突發事件所困擾，以便及時獲得重大股票動態的提醒。</li>
<li>使用免費的 Simply Wall St 應用程序更聰明地投資，提供全球每個股票市場的詳細見解。</li>
</ul>
<h2>考慮其他策略？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

唯科科技

<p>隨着全球市場對經濟變化的反應，亞洲的小型股展現出獨特的投資機會。值得關注的公司包括廣東福信科技、MYS 集團和廈門唯科科技，每家公司都展現出強勁的基本面和增長潛力。儘管市場波動，廣東福信的盈利增長令人印象深刻；MYS 集團的財務健康狀況良好，超越了行業盈利水平；而廈門唯科科技在市場波動中保持了穩健的表現。投資者被鼓勵探索這些未被發現的投資機會，以期在不斷變化的市場環境中實現潛在增長</p>

<p>As global markets react to recent economic shifts, including the Federal Reserve's interest rate cut and ongoing trade discussions between the U.S. and China, small-cap stocks have shown notable sensitivity to these changes, with indices like the Russell 2000 experiencing significant gains. In this dynamic environment, identifying promising small-cap stocks in Asia can offer unique opportunities for investors seeking growth potential amidst evolving market conditions.</p>
<div class="lb-trans"><p>隨着全球市場對近期經濟變化的反應，包括美聯儲的降息和美國與中國之間持續的貿易討論，小型股對這些變化表現出顯著的敏感性，像羅素 2000 指數經歷了顯著的漲幅。在這個動態環境中，識別亞洲有前景的小型股可以為尋求增長潛力的投資者提供獨特的機會，尤其是在不斷變化的市場條件下。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In Asia</h3>
<div class="lb-trans"><h3>亞洲十大未被發現的基本面強勁的寶藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ruentex Interior Design</td>
<td>NA</td>
<td>32.58%</td>
<td>38.70%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Hangzhou Fortune Gas Cryogenic Group</td>
<td>NA</td>
<td>15.44%</td>
<td>21.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Jiangyin Haida Rubber And Plastic</td>
<td>13.80%</td>
<td>8.51%</td>
<td>-6.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Shanghai Haixin Group</td>
<td>2.04%</td>
<td>-5.07%</td>
<td>5.13%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Yibin City Commercial Bank</td>
<td>82.57%</td>
<td>-1.19%</td>
<td>15.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Lucky Cement</td>
<td>47.61%</td>
<td>4.43%</td>
<td>16.92%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Guangdong Transtek Medical Electronics</td>
<td>14.33%</td>
<td>-9.94%</td>
<td>1.91%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Nacity Property Service GroupLtd</td>
<td>6.90%</td>
<td>6.11%</td>
<td>-8.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Hospital Corporation of China</td>
<td>137.48%</td>
<td>28.23%</td>
<td>50.23%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>SBS Philippines</td>
<td>29.71%</td>
<td>3.10%</td>
<td>-49.78%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名稱</th>
<th>負債權益比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>瑞豐室內設計</td>
<td>NA</td>
<td>32.58%</td>
<td>38.70%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>杭州富通氣體低温集團</td>
<td>NA</td>
<td>15.44%</td>
<td>21.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>江陰海達橡塑</td>
<td>13.80%</td>
<td>8.51%</td>
<td>-6.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集團</td>
<td>2.04%</td>
<td>-5.07%</td>
<td>5.13%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>宜賓市商業銀行</td>
<td>82.57%</td>
<td>-1.19%</td>
<td>15.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>幸運水泥</td>
<td>47.61%</td>
<td>4.43%</td>
<td>16.92%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>廣東創科醫療電子</td>
<td>14.33%</td>
<td>-9.94%</td>
<td>1.91%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>納城物業服務集團有限公司</td>
<td>6.90%</td>
<td>6.11%</td>
<td>-8.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>中國醫院集團</td>
<td>137.48%</td>
<td>28.23%</td>
<td>50.23%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>SBS 菲律賓</td>
<td>29.71%</td>
<td>3.10%</td>
<td>-49.78%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 2395 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲未被發現的基本面強勁的寶藏股篩選器中的 2395 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是篩選器中一些選擇的預覽。</p>
</div><h2>Guangdong Fuxin Technology (SHSE:688662)</h2>
<div class="lb-trans"><h2>廣東富信科技 (SHSE:688662)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Guangdong Fuxin Technology Co., Ltd. engages in the research, development, production, and sale of semiconductor thermoelectric materials with a market cap of approximately CN¥5.10 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 廣東富信科技有限公司從事半導體熱電材料的研究、開發、生產和銷售，市值約為 51 億元人民幣。</p>
</div><p><strong>Operations:</strong> With a market cap of approximately CN¥5.10 billion, the company focuses on semiconductor thermoelectric materials. It generates revenue primarily through the sale of these materials, while managing costs associated with research and development as well as production. The financial performance is influenced by its gross profit margin trends over time.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司專注於半導體熱電材料，市值約為 51 億元人民幣。其收入主要通過銷售這些材料獲得，同時管理與研發和生產相關的成本。財務表現受到其毛利率趨勢的影響。</p>
</div><p>Fuxin Technology, a smaller player in the semiconductor space, has demonstrated impressive earnings growth of 68.6% over the past year, outpacing the industry's 10.4%. Despite this strong performance, its earnings have declined by 32.2% annually over five years. Recent financials show sales at CNY 259.21 million for H1 2025 compared to CNY 251.06 million last year, with net income slightly down to CNY 20.35 million from CNY 22.26 million previously. The company has more cash than debt and maintains positive free cash flow, although its share price remains highly volatile recently.</p>
<div class="lb-trans"><p>富信科技作為半導體領域的較小參與者，過去一年表現出 68.6% 的盈利增長，超過行業的 10.4%。儘管表現強勁，但其盈利在過去五年中年均下降 32.2%。最近的財務數據顯示，2025 年上半年銷售額為 2.5921 億元人民幣，而去年為 2.5106 億元人民幣，淨收入略降至 2035 萬元人民幣，之前為 2226 萬元人民幣。該公司現金多於債務，並保持正的自由現金流，儘管其股價最近波動較大。</p>
</div><ul>
<li>Dive into the specifics of Guangdong Fuxin Technology here with our thorough health report.</li>
<li>Review our historical performance report to gain insights into Guangdong Fuxin Technology's's past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏深入瞭解廣東富信科技的具體情況，查看我們的詳細健康報告。</li>
<li>查看我們的歷史表現報告，以獲取廣東富信科技過去表現的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c000b4fb-abb7-48d0-a59e-8933a5bb9153/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/c000b4fb-abb7-48d0-a59e-8933a5bb9153/chart/debt-equity-history-analysis"/></p>
<p>SHSE:688662 Debt to Equity as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月，SHSE:688662 負債權益比</p>
</div><h2>MYS Group (SZSE:002303)</h2>
<div class="lb-trans"><h2>MYS 集團 (SZSE:002303)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> MYS Group Co., Ltd. develops, produces, and sells packaging products in China and internationally with a market cap of CN¥7.20 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> MYS 集團有限公司在中國及國際上開發、生產和銷售包裝產品，市值為 72 億元人民幣。</p>
</div><p><strong>Operations:</strong> MYS Group generates revenue through the development, production, and sale of packaging products both in China and internationally. The company's market capitalization stands at approximately CN¥7.20 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> MYS 集團通過開發、生產和銷售包裝產品在中國及國際上獲得收入。公司的市值約為 72 億元人民幣。</p>
</div><p>MYS Group is capturing attention with its robust financial performance, reporting a net income of CNY 176.1 million for the first half of 2025, up from CNY 150.15 million the previous year. The company's earnings growth of 25.8% significantly outpaces the packaging industry's -3.1%, highlighting its strong market position and operational efficiency. Despite an increase in the debt-to-equity ratio from 17.6% to 30.8% over five years, MYS maintains more cash than total debt, indicating solid financial health and stability in covering interest payments comfortably. Additionally, trading at a slight discount to fair value suggests potential investment appeal for those seeking growth opportunities in Asia's dynamic markets.</p>
<div class="lb-trans"><p>MYS 集團憑藉其強勁的財務表現引起關注，2025 年上半年淨收入為 1.761 億元人民幣，較去年 1501.5 萬元人民幣有所增長。公司的盈利增長為 25.8%，顯著超過包裝行業的-3.1%，突顯其強大的市場地位和運營效率。儘管負債權益比在五年內從 17.6% 上升至 30.8%，MYS 仍保持現金多於總債務，表明其財務健康和穩定，能夠輕鬆覆蓋利息支付。此外，交易價格略低於公允價值，表明對於尋求增長機會的投資者在亞洲動態市場中的潛在吸引力。</p>
</div><ul>
<li>Navigate through the intricacies of MYS Group with our comprehensive health report here.</li>
<li>Evaluate MYS Group's historical performance by accessing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏通過我們的綜合健康報告深入瞭解 MYS 集團的複雜情況。</li>
<li>通過訪問我們的歷史表現報告評估 MYS 集團的歷史表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/156d5255-b010-4783-bcd2-6ceef5f53187/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/156d5255-b010-4783-bcd2-6ceef5f53187/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:002303 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月，SZSE:002303 盈利和收入增長</p>
</div><h2>Xiamen Voke Mold &amp; Plastic Engineering (SZSE:301196)</h2>
<div class="lb-trans"><h2>廈門唯科模具與塑料工程 (SZSE:301196)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Xiamen Voke Mold &amp; Plastic Engineering Co., Ltd. specializes in the production and sale of high-precision molds, injection products, and health products, with a market capitalization of approximately CN¥13.29 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 廈門唯科模具與塑料工程有限公司專注於高精度模具、注塑產品和健康產品的生產與銷售，市值約為 132.9 億元人民幣。</p>
</div><p><strong>Operations:</strong> Voke Mold's revenue is primarily derived from the production and sale of high-precision molds, injection products, and health products, totaling CN¥2.09 billion. The company has a market capitalization of approximately CN¥13.29 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 唯科模具的收入主要來自高精度模具、注塑產品和健康產品的生產與銷售，總計為 20.9 億元人民幣。該公司的市值約為 132.9 億元人民幣。</p>
</div><p>Xiamen Voke Mold &amp; Plastic Engineering, a smaller player in the industry, recently saw its earnings grow by 14.4%, outpacing the broader Machinery sector's 4% rise. Despite a volatile share price in recent months, the company has demonstrated robust financial health with more cash than total debt and positive free cash flow. Its debt-to-equity ratio has increased from 0.7 to 1.3 over five years, but interest payments remain well-covered by profits. Recent transactions include a notable acquisition of a 2.9% stake valued at CNY 280 million, reflecting investor confidence and potential for future growth within this niche market segment.</p>
<div class="lb-trans"><p>廈門唯科模具與塑料工程作為行業中的較小參與者，最近其盈利增長 14.4%，超過了更廣泛的機械行業 4% 的增長。儘管最近幾個月股價波動較大，但該公司展現出強勁的財務健康，現金多於總債務，並保持正的自由現金流。其負債權益比在五年內從 0.7 上升至 1.3，但利潤仍能很好地覆蓋利息支付。最近的交易包括一項價值 2.8 億元人民幣的 2.9% 股份的顯著收購，反映出投資者的信心和在這一細分市場未來增長的潛力。</p>
</div><ul>
<li>Take a closer look at Xiamen Voke Mold &amp; Plastic Engineering's potential here in our health report.</li>
<li>Explore historical data to track Xiamen Voke Mold &amp; Plastic Engineering's performance over time in our Past section.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的健康報告中更深入地瞭解廈門唯科模具與塑料工程的潛力。</li>
<li>探索歷史數據，以追蹤廈門唯科模具與塑料工程在我們過去部分的表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eac44be0-d376-4d04-a061-9284cfecf929/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/eac44be0-d376-4d04-a061-9284cfecf929/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:301196 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>SZSE:301196 截至 2025 年 9 月的收益和收入增長</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><ul>
<li>Get an in-depth perspective on all 2395 Asian Undiscovered Gems With Strong Fundamentals by using our screener here.</li>
<li>Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.</li>
<li>Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.</li>
</ul>
<div class="lb-trans"><ul>
<li>使用我們的篩選器在這裏深入瞭解 2395 個具有強大基本面的亞洲未被發現的寶石。</li>
<li>是這些公司的股東之一嗎？通過在 Simply Wall St 中添加您的投資組合，確保您不會被突發事件所困擾，以便及時獲得重大股票動態的提醒。</li>
<li>使用免費的 Simply Wall St 應用程序更聰明地投資，提供全球每個股票市場的詳細見解。</li>
</ul>
</div><h2>Contemplating Other Strategies?</h2>
<div class="lb-trans"><h2>考慮其他策略？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

亞洲未被發現的寶石：三隻具有良好潛力的小盤股